EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
40 hedge funds and large institutions have $101M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+7
Holders Change %
+21.21%
% of All Funds
0.91%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
12
Increased
9
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Jennison Associates
New York
|
$8.43M |
2 |
AC
2
Armistice Capital
New York
|
$5.36M |
3 |
DM
3
Deerfield Management
New York
|
$4.19M |
4 |
HCM
4
Highbridge Capital Management
New York
|
$2.58M |
5 |
SCM
5
Stonepine Capital Management
Bend,
Oregon
|
$2.09M |